Saturday, September 20, 2014

Top 10 Railroad Companies To Buy For 2014

Since 2008, domestic crude oil production has soared. In fact, the U.S. pumped out more oil last year than it has in at least two decades.

Production has grown so rapidly that midstream companies, which are working tirelessly to build out the pipeline infrastructure necessary to support the domestic oil boom, just can't seem to keep up. We're simply pumping out way too much oil.

That's why railroads and other alternative transport methods have become increasingly important in recent years, giving pipelines a run for their money. And if recent developments are any indication, rail-based crude shipments should continue to grow over the next several years.

That's good news for Warren Buffett's Berkshire Hathaway, which bought out the nation's largest railroad company more than three years ago. Let's see how that bet might turn out.

Buffett's BNSF optimistic about crude shipments
Buffett's decision to take over Burlington Northern Santa Fe LLC, or BNSF, in 2009 was predicated largely upon his belief that a recovering U.S. economy would boost growth in the highly cyclical rail industry. While the bet has turned out to be a great one so far, its future success will likely be driven by further growth in crude oil shipments.

Top 5 Internet Stocks To Buy Right Now: Pernix Therapeutics Holdings Inc (PTX)

Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company�� branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.

The Company�� customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.

ALDEX Line

ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company�� ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongestant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.

BROVEX Line

The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.

CEDAX Line

CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.

NATROBA Line

NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.

PEDIATEX Line

As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respiratory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.

REZYST Line

REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.

Product Candidates in Development

Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent.

Top 10 Railroad Companies To Buy For 2014: Collectors Universe Inc. (CLCT)

Collectors Universe, Inc. provides authentication and grading services to dealers and collectors of high-value coins, trading cards, event tickets, autographs, memorabilia, and stamps in the United States. It offers authentication and grading services for coins under the Professional Coin Grading Service brand name; sports and trading cards under the Professional Sports Authenticator (PSA) brand name; vintage autographs and memorabilia under the PSA/DNA authentication services brand name; and stamps under the Professional Stamp Experts brand name. The company also publishes authoritative price guides, rarity reports, and other collectibles data to provide collectors with information. In addition, it operates the Certified Coin Exchange business-to-business Website, certifiedcoinexchange.com, where dealers can sell and purchase certified coins and other certified collectibles; and Collectors Corner Business-to-Consumer Website, collectorscorner.com, a business-to-consumer W ebsite where consumers can visit, identify, search, sort over, and select for purchase coins, trading cards, and items of currency that are certified by the company, as well as Collectors Clubs for coin, currency, and trading card collectors; and manages and operates collectibles trade shows and conventions. The company provides its services to dealers, collectors, and retail buyers and sellers of collectibles. Collectors Universe, Inc. was founded in 1986 and is headquartered in Santa Ana, California.

Advisors' Opinion:
  • [By Jeff Hwang]

    Such multiple expansion may be a natural product of time (i.e., older cards naturally carry larger premiums over time), or more likely a combination of time and the card removal effect. That is, over time, the best examples of a given card get graded by Beckett Grading Services or Professional Sports Authenticator (PSA), a division of Collectors Universe (NASDAQ: CLCT  ) , and are thus removed from the pool of ungraded cards; as a consequence, the value of ungraded cards declines in relation to the value of graded cards (or the value of graded cards rises in relation to ungraded cards), resulting in multiple expansion.

Top 10 Railroad Companies To Buy For 2014: Lamar Advertising Company(LAMR)

Lamar Advertising Company, together with its subsidiaries, provides outdoor advertising services. Its outdoor advertising displays include billboards, such as bulletins, posters, and digital billboards; and logo signs to advertise nearby gas, food, camping, lodging, and other attractions. The company also offers transit advertising displays that provide advertising space on the exterior and interior of public transportation vehicles, transit shelters, and benches. As of December 31, 2011, it owned and operated approximately 143,000 billboard advertising displays in 44 states, Canada, and Puerto Rico; operated approximately 112,000 logo advertising displays in 21 states and the province of Ontario, Canada; operated approximately 30,000 transit advertising displays in 16 states, Canada, and Puerto Rico; and owned and operated approximately 1,400 digital billboard advertising displays in 40 states, Canada, and Puerto Rico. The company was founded in 1989 and is headquartered in Baton Rouge, Louisiana.

Advisors' Opinion:
  • [By Steven Russolillo]

    WATCH FOR: First-Quarter Productivity (8:30 a.m. Eastern Time): seen -1.1%; previously +1.8%. First-Quarter Unit Labor Costs (8:30): seen +2.8%; previously -0.1%. March Consumer Credit (3:00): seen +$16.1 B; previously $16.5B. Allergan(AGN), AOL(AOL), Avis Budget(CAR), CenturyLink, Chesapeake Energy(CHK), CF Industries(CF), Devon Energy(DVN), Duke Energy(DUK), Dynergy, Hertz, Humana, Keurig Green Mountain(GMCR), Lamar Advertising(LAMR), Molson Coors/Miller, Mondelez, Prudential, SolarCity(SCTY), Sotheby's(BID), Tesla Motors(TSLA), Transocean and 21st Century Fox are among companies scheduled to report quarterly results.

  • [By Paul Ausick]

    CBS Outdoor Americas Inc. is currently a wholly owned subsidiary of CBS Corp. (NYSE: CBS) which will offer 20 million shares in an anticipated price range of $26 to $28 a share. Following the tax-free spin-off, CBS Outdoor will become a REIT. CBS first announced plans for the spin-off in January 2013. Since then, share prices for outdoor advertising firms Lamar Advertising Co. (NASDAQ: LAMR) and Clear Channel Outdoor Holdings Inc. (NYSE: CCO) have risen about 30%.

Top 10 Railroad Companies To Buy For 2014: Cambridge Heart Inc (CAMH)

Cambridge Heart, Inc., incorporated on January 16, 1990, is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. The Company's products incorporate its technology for the measurement of Microvolt T-Wave Alternans (MTWA). The MTWA Test is conducted by elevating the patient's heart rate through exercise as performed on a treadmill similar to a stress test, pharmacologic agents, or pacing with electrical pulses.

The Company's products, including its first generation HearTwave System and second generation HearTwave II System, CH 2000 Cardiac Stress Test System, MTWA original equipment manufacturer (OEM) Module (MTWA Module) and Micro-V Alternans Sensors have received 510(k) clearance from the United States Food and Drug Administration (FDA) for sale in the United States. The Company's products have also received the Conformite Europeenne (CE) mark for sale in Europe. The Company's first generation HearTwave System, CH 2000 Cardiac Stress Test System and the HearTwave II System have been approved for sale by the Japanese Ministry of Health Labor and Welfare.

The Company's 510(k) clearance allows the Company's MTWA Test to be used to test patients with known, suspected, or at risk of ventricular tachyarrhythmia and/or sudden cardiac arrest, and allows the claim that its MTWA Test is predictive of those events. The MTWA Module is designed to work with existing cardiac stress test platforms distributed by other manufacturers as an add-on module to enable MTWA testing to be performed using the Company's Micro-V Alternans Sensors.

The Company's HearTwave II System, which has replaced the Company's original HearTwave System, is used to perform both MTWA testing and standard cardiac stress testing. In addition to MTWA measurement, the Company's HearTwave II System is a cardiac diagnostic system designed to support a range of customized protocols for the conduct of cardiac exercise stress testing. The Comp! any's Micro-V Alternans Sensors are single patient use, multi-segment electrodes. The Company's CH2000 is a cardiac diagnostic system designed to support a range of customized protocols for the conduct and measurement of cardiac exercise stress testing.

The Company competes with GE Medical Systems.

Advisors' Opinion:
  • [By Peter Graham]

    Last Friday, small cap stocks Cambridge Heart, Inc (OTCMKTS: CAMH), Abby Inc (OTCMKTS: ABBY) and Grillit Inc (OTCMKTS: GRLT) surged 176.92%, 71.2% and 24.07%, respectively. Of course, that was last week and today is a new trading week. So what should investors and traders alike be prepared for this week with these three small caps? Here is a closer look to help you decide on an investing or trading strategy:

    Cambridge Heart, Inc (OTCMKTS: CAMH) Recently Changed Its Board

    Small cap Cambridge Heart, Inc is a healthcare company engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. On Friday, Cambridge Heart, Inc surged 176.92% to $0.018 for a market cap of $1.80 million plus CAMH is up 20% since the start of the year and down 86.1% over the past five years according to Google Finance.

Top 10 Railroad Companies To Buy For 2014: Pozen Inc.(POZN)

POZEN Inc., a pharmaceutical company, develops products for the treatment of acute and chronic pain, and other pain-related conditions in the United States. Its products include Treximet for acute treatment of migraine attacks with or without aura in adults; and VIMOVO for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as to decrease the risk of developing gastric ulcers in patients at risk of developing non-steroidal anti-inflammatory drugs (NSAID)-associated gastric ulcers. The company also develops PA32540, a product candidate, which is under 2 pivotal Phase 3 trials for the secondary prevention of cardiovascular disease in patients at risk for gastric ulcers. It has collaborations with GlaxoSmithKline for the development and commercialization of proprietary combinations of a triptan and a long-acting NSAID; and with AstraZeneca AB for the development and commercialization of proprietary fixed dose combi nations of the proton pump inhibitor esomeprazole magnesium with the NSAID naproxen. The company was founded in 1996 and is headquartered in Chapel Hill, North Carolina.

Advisors' Opinion:
  • [By James E. Brumley]

    At first glance, POZEN Inc. (NASDAQ:POZN) doesn't look like anything more than a volatile mover and shaker, currently overbought, and due for a dip. And truth be told, POZN is overbought and due for a pullback (and will be even more so, given this morning's bullish pre-market activity). When you take a step back and look at the much-bigger-picture though, you'll find that POZEN Inc. is only at the beginning of what could be a sizeable move for investors willing to give it some time.

Top 10 Railroad Companies To Buy For 2014: B2Gold Corp (BTG)

B2Gold Corp. (B2Gold) is a gold producer with mining operations in Nicaragua and a portfolio of development and exploration assets in Colombia, Nicaragua and Uruguay. It operates the Libertad Mine and the Limon Mine in Nicaragua. It owns or has an interest in the Gramalote and Mocoa properties in Colombia, and the Bellavista property in Costa Rica. La Libertad Mine is located 110 kilometers east of Managua. The Limon Mine is located approximately 100 kilometers northwest of Managua and 20 kilometers from the Pan- American Highway. The Otjikoto gold project is located approximately 300 kilometers north of Namibia�� capital city, Windhoek. The Gramalote property is located approximately 230 kilometers northwest of the Colombian capital of Bogota and approximately 80 kilometers northeast of Medellin. The Gramalote property area is covered by 31 contiguous claim blocks totaling 42,790.09 hectares. In Jnauary 2013, the Company acquired CGA Mining Ltd. Advisors' Opinion:
  • [By Johanna Bennett]

    Analyst John Bridges and his team like Goldcorp (GG), B2Gold (BTG) and Eldorado (EGO), and feel Buenaventura (BVN) is a serious laggard with likely improved results in the second half of 2014. They write:

Top 10 Railroad Companies To Buy For 2014: Boral Ltd (BLD)

Boral Limited (Boral), is engaged in the manufacture and supply of building and construction materials in Australia, the United States and Asia. The Company�� operating segments include Construction Materials & Cement, Building Products, Boral Gypsum, and Boral USA. The Construction Materials & Cement is engaged in quarries, concrete, asphalt, transport, landfill, property, cement and concrete placing. The Building Products segment is engaged in Australian bricks, roof tiles, masonry, timber products and windows. The Boral Gypsum involves Australian and Asian plasterboard. The Boral USA is engaged in Bricks, cultured stone, roof tiles, fly ash, concrete and quarries. Advisors' Opinion:
  • [By Eric Lam]

    Ballard Power (BLD), which designs and manufactures hydrogen fuel cells, slumped 15 percent to C$1.42, the biggest decline since March. The company yesterday said it will sell about 9 million units at $1.40 a unit for proceeds of about $12.6 million. The cash generated will be used to fund working capital, support growth and general corporate purposes, the company said.

No comments:

Post a Comment